Bronchopulmonary dysplasia (BPD) is one of the most frequent causes of long-term morbidities in preterm infants 1 . In addition to respiratory problems, BPD can also lead to neurodevelopmental retardation. Many factors including prematurity, mechanical ventilation, oxygen therapy or genetic factors play a role in the pathogenesis of BPD 2 . Among these factors antenatal infection and inflammation also play an important role. During the inflammatory process, which emerges as a result of different causes as prenatal, postnatal infection, mechanical ventilation, hypoxic injury, and hyperoxic damage many proinflammatory and anti-inflammatory cytokines play a role. Some studies have investigated the correlation between BPD and pro-inflammatory cytokines as interleukin (IL)-1, 6, 8, TNF-α, and anti-inflammatory cytokines as IL-10 3, 4 .
Some studies have also demonstrated the potentially significant role of IGF-1, which involves pulmonary alveolarization and healing of tissue injuries, in the development of BPD 5, 6 .
In this study, we aimed to reveal the correlations between the development of BPD in premature infants, IGF-1 levels in serum and tracheal aspirate (TA) and cytokine levels in TA measured on separate days during the postnatal period of these infants.
Material and Methods
This prospective study was conducted in the Neonatal Intensive Care Unit (NICU) of Uludag University Faculty of Medicine, between January 2015 and December 2015. Approval of the Ethics Committee of Uludag University Faculty of Medicine was obtained on 01. 28 .2014 (decision # 2014-2/24). Written and undersigned, enlightened and completed consent forms were obtained from all parents/ guardians of all infants.
A total of 40 premature infants born at a gestational age of ≤ 32 weeks were enrolled in this prospective study. Infants with major congenital anomalies and infants exited during the study period were excluded from the study. Demographic data and follow-up characteristics of the patients were recorded.
Venous blood samples were drawn from all cases on postnatal day-1, 3, 7, 21 and 28 and centrifuged. Serum portions of the blood samples were transferred into Eppendorf tubes and stored at -20 o C.
Tracheal aspirate samples were collected during routine endotracheal suction on the first day of life. For the suctioning procedure, the infant was positioned in a supine posture with the head in the midline, then, 1 ml of saline was instilled into the endotracheal tube, after that the ventilator was reconnected for three to four breaths, and the endotracheal tube was suctioned once or twice with a suction catheter (6 French gauge). The catheter was rinsed with 2 ml of saline, and the aspirate was collected into a sterile trap. The samples were centrifuged at 3,000 rpm for 5 minutes Data is presented as median (minimum-maximum) or n (%) as appropriate. (Table I ).
Serum IGF-1 values of the patients who developed BPD were found to be significantly lower (Table II) . When patients with diagnosis of severe BPD were compared with those diagnosed as mild to moderate BPD, IGF-1 levels in the group who developed severe BPD had significantly lower IGF-1 levels (Table III) .
ROC analyses were performed to evaluate usability of low serum IGF-1 level as a parameter in the prediction of BPD. Therefore, cut-off values for serum IGF-1 for postnatal day-1 (16.17 ng/ml), day-3 (16.12 ng/ml), day-7 (18.31 ng/ml), day-21 (16.59) and day-28 (18.14 ng/ml) were determined as indicated.
Corresponding measurements below these levels were detected to have 80% specificity and 100% sensitivity (Table IV) .
Thirty-two patients (total N=32) out of who completed the study were intubated and samples of TA were obtained from these 32 patients. Thirteen of these 32 patients developed BPD and the remaining 19 patients did not. Levels of IGF-1, IL-6, IL-8, IL-10 and TNF-alfa in TA samples of the patients in both groups were analyzed. Any intergroup difference between IGF-1 levels was not detected in TA samples of the patients who developed BPD, while cytokine levels in TA samples of the patients in whom BPD developed were significantly higher (Table V) . In Table VI , groups were compared according to severity of BPD.
Discussion
In line with evolving neonatal care in recent years, survival rates of very low birth infants have increased. Current studies have been performed to decrease morbidities of these surviving infants. BPD leads the way among these relevant issues 1 .
The incidence of BPD increases inversely with gestational age. In our center 276 premature infants born at 24-36 gestational ages in the year 2006 were investigated and BPD was detected in 30% of these infants 10 . Nievas et al. 11 reported that incidence of BPD increased up to 70 percent. In the present study, we examined premature infants born at a gestational age of ≤ 32 weeks and BPD developed in 14 of 40 (35%) infants included in the study.
Risk factors of BPD have been investigated in many studies and data indicating association between BPD and prematurity, inflammation, oxygen therapy, surfactant deficiency, PDA, barotrauma, volutrauma, maternal preeclampsia, and chorioamnionitis have been detected 10, 12 .
Maternal chorioamnionitis and premature membrane rupture have been thought to lead to intrauterine inflammation with resultant development of BPD. The study by Ozkan 10 also supports these assumptions. However, data obtained from our study do not support the presence of a significant correlation between development of BPD, EMR, and chorioamnionitis.
Similarly, neonatal sepsis can presumably lead to development of BPD 2 . In our study, a significant difference could not be found as for sepsis between infants who developed and did not develop BPD.
Maternal preeclampsia has been shown to increase frequency and severity of BPD 13 . In our study preeclampsia was detected in comparable number of infants who developed and did not develop eclampsia.
Besides, antenatal steroid use did not differ significantly between both groups as for gestational diabetes and IUGR and 1 st and 5 th minute Apgar scores of both groups were also comparable.
In our study, the number of days under mechanical ventilation, oxygen therapy and TPN of intubated cases with BPD were found to be significantly higher when compared with those in whom BPD did not develop (p < 0.05). Mechanical ventilation plays an important role in the development of BPD by inducing barotrauma and inflammation in developing alveoli and risk of BPD increases with increasing mechanical ventilation time 1, 14, 15 . A significant correlation was not detected between noninvasive mechanical ventilation times and development of BPD.
Various factors have been implicated in the pathogenesis of BPD including exposure to mechanical ventilation, increased levels of free oxygen radicals, immature antioxidant system, maternal chorioamnionitis, postnatal infections, inflammation caused by pro-inflammatory cytokines released from neutrophils and macrophages, symptomatic PDA, deficient p o s t n a t a l p r o t e i n i n t a ke a n d g e n e t i c predisposition predominantly prematurity and pulmonary immaturity.
In a study by Ohkawa et al. 5 the authors demonstrated that lower levels of IGF-1 at birth increased stepwise during the first 8 weeks of life. However, Löfqvist et al. 6 displayed the association between decrease in IGF-I levels during early postnatal period and development of BPD. Serum IGF-1 levels increase in line with gestational age, however in infants who developed BPD its levels do not increase. Also, in infants who developed BPD, serum IGF-1 levels were statistically significantly lower when compared with those without BPD A significant increase was not observed in IGF-1 levels in line with increasing age.
IGF-1 has been thought to play a role in the development of BPD by effecting alveolar angiogenesis especially through VEGF signalization 16 . Hellström et al. 17 detected lower IGF-1 levels in premature infants in whom comorbidities as ROP, IVH and NEC had developed. In another study, the usability of lower IGF-1 levels as a predictive parameter for the development of BPD was investigated. Low specificity and sensitivity of IGF-1 levels of <9.67 ng/ml, on 1st and < 7.26 ng/ml on 7th postnatal days in the prediction of BPD were determined 18 . However, this study has demonstrated that lower IGF-1 levels could be used in the prediction of BDP with higher sensitivity. Therefore, predictive cut-off values were determined for postnatal on day-1, 3, Capoluongo et al. 19 demonstrated increased levels of free IGF-1 levels in TA fluid samples collected at early phase of development of BPD in premature infants. However, in our study, any correlation could not be found between IGF-1 levels in TA samples of intubated infants and development of BPD.
The increase in concentrations of inflammatory cytokines in TA samples is associated with pulmonary inflammation. Major proinflammatory cytokines playing a role in this process progressing to BPD are IL-6, 8 and TNF-alpha. The relationship between antiinflammatory cytokine IL-10 and development of BPD has been also investigated in various studies 4 .
Increased concentrations of pro-inflammatory cytokine IL-6 have been demonstrated in TA samples collected on the first day of their lives of infants with RDS and BPD 20 . Bagchi et al. 21 reported significantly higher levels of IL-6 activity in pulmonary lavage fluids of infants who developed BPD which were maintained for the first 2 weeks of their lives and IL-6 levels started to drop after postnatal 28th days. Similarly, correlations between increased IL-6 concentrations in TA samples and duration of mechanical ventilation and higher IL-6 levels in infants who developed BPD have been demonstrated 22 . Tullus et al. 11 evaluated correlations between levels of various pro-inflammatory cytokines in TA samples of ventilated premature infants and development of BPD and detected significantly higher levels of IL-6 concentrations in TA samples in infants who developed BPD. In compliance with literature findings we also detected significantly higher levels of IL-6 in TA samples of infants who developed BPD.
Kotecha et al. 23 detected higher IL -8 concentrations in TA samples in infants who developed BPD within the first 10 days of their lives. In cases with severe disease, IL-8 levels increase in pulmonary injury, however this condition is not specific for BPD. In a study by Shimotake et al. 24 higher IL-8 levels in TA samples stimulated by NF-kB were detected in ventilated premature infants. Also in our study, we detected higher IL-8 levels in TA samples of premature infants collected at first postnatal day of premature infants.
TNF-α is one of the important components of cytokine-mediated host defense against bacteria, mycobacteria, fungi and parasites and various studies have suggested its potential association with BPD 25 . In a study performed, higher TNF-α levels in TA samples obtained within 2 hours after birth had been associated with worse pulmonary outcomes 26 . In another study, correlations between increased TNF-α levels in TA samples and duration of mechanical ventilation were demonstrated in infants who developed BPD 22 . In our study, TNF-α concentrations in TA samples collected within the first postnatal 24 hours were significantly higher in infants who developed BPD when compared with the infants who did not.
In the literature, controversial outcomes have been reported concerning the role of IL-10 4 reported that they have found significantly lower IL-10 levels in both serum and TA sample of premature infants who subsequently developed BPD. Conversely, in our study IL-10 levels in TA samples of the premature infants who developed BPD were higher relative to those who did not. Because of all this, the serial measurement of IL-10 levels, in a large sample of preterm infants after birth, are warranted in order to elucidate the association between development of BPD and IL-10 levels 4 .
As a result of this study, significantly lower serum IGF-1 levels were detected in babies who developed BPD relative to those who did not. Besides levels of cytokines as IL-6, IL-8, IL-10, TNF-alpha in TAs obtained from intubated infants were significantly higher in infants who developed BPD when compared with those who did not. An association between IGF-1 levels in TA samples of intubated infants and development of BPD was not detected. Besides in our study, it has been determined that lower serum IGF-1 levels can be used in the prediction of BPD with higher sensitivity and thus relevant cut-off values were specified.
It has been conceived that precise determination of the roles of various cytokines in the development of the lungs and pulmonary injury, subsequently specification of treatment strategies to be developed which will target cytokines and/or their receptors will be beneficial in preventing BPD and/or related deaths in premature infants. To determine the correlation between BPD and serum IGF-1 levels and its potential use as an early marker for BPD; further randomized controlled studies are required.
Limitations of our study include limited number of cases and failure to analyze serum cytokine levels. It has been thought that differences in study outcomes cited in the literature may stem from timing of sample collection and characteristics of the study groups.
